Qing-Jie Chen (Qingjie Chen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Traumatic Brain Injury

Endoplasmic Reticulum

Cognitive Impairment

Top Venues

International journal of endocrinology

BioFactors (Oxford, England)

Molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuting Yuan, Yue Zhang, Min Lei, Xiying Guo, Xiaosong Yang, Changhan Ouyang, Chao Liu, Qing-Jie Chen
Effects of DPP4 Inhibitors as Neuroprotective Drug on Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review. International journal of endocrinology 2024 (2024)
Yuting Yuan, Yue Zhang, Min Lei, Xiying Guo, Xiaosong Yang, Changhan Ouyang, Chao Liu, Qing-Jie Chen
Effects of DPP4 Inhibitors as Neuroprotective Drug on Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review. International journal of endocrinology 2024 (2024)
Zichen Gui, Jiawen Wang, Yue Zhang, Binbin Wan, Zhiqiang Ke, Zhanhong Ren, Xiaosong Yang, Min Lei, Xiying Guo, Xiufen Liu, Changhan Ouyang, Ninghua Wu, Qing-Jie Chen
Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice. BioFactors (Oxford, England) (2023)
Ning-Hua Wu, Yu Ye, Bin-Bin Wan, Yuan-Dong Yu, Chao Liu, Qing-Jie Chen
Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases. Molecular neurobiology 58 (11) (2021)